Friday, July 17

Browsing: 5Fraction

Survivors

03 Rapid Uptake of 5-Fraction Breast Radiotherapy in the US (NCDB 2020–2023) With Persistent Access Disparities

By NewsCancerJuly 17, 20260

BackgroundUltra-hypofractionated breast radiotherapy (RT) delivered in 5 fractions is supported by randomized trial evidence and is increasingly incorporated into contemporary…

Support

04 National Adoption of Ultra-Hypofractionated (5-Fraction) External Beam Radiation Therapy in the United States, 2020–2023: An NCDB Analysis

By NewsCancerJuly 15, 20260

BackgroundUltra-hypofractionated radiation therapy (RT), including 5-fraction regimens, has expanded across multiple disease sites, offering greater convenience and potentially lower resource…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

Browsing: 5Fraction

03 Rapid Uptake of 5-Fraction Breast Radiotherapy in the US (NCDB 2020–2023) With Persistent Access Disparities

04 National Adoption of Ultra-Hypofractionated (5-Fraction) External Beam Radiation Therapy in the United States, 2020–2023: An NCDB Analysis

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma

Latest Post

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

Subscribe to Updates

What's Hot

Browsing: 5Fraction